TuHURA Biosciences (HURA) Other Non-Current Liabilities (2011 - 2025)
TuHURA Biosciences (HURA) posted quarterly Other Non-Current Liabilities of $84985.0 for Q3 2025, up 102.78% quarter-over-quarter from -$3.1 million in Q1 2025.
TuHURA Biosciences (HURA) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
TuHURA Biosciences' Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $84985.0 for Q3 2025.
- In Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $84985.0; the TTM figure through Sep 2025 stood at $84985.0 (changed N/A YoY), while the FY2023 annual figure was $137000.0, changed N/A from the prior year.
- Other Non-Current Liabilities for Q3 2025 stood at $84985.0, up from -$3.1 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $137000.0 in Q4 2023, with the low at -$3.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 84,985.00 |
| Mar 31, 2025 | -3.06 Mn |
| Dec 31, 2023 | 137,000.00 |
| Jun 30, 2020 | 8.52 Mn |
| Mar 31, 2020 | 8.38 Mn |
| Dec 31, 2019 | 8.31 Mn |
| Sep 30, 2019 | 8.28 Mn |
| Mar 31, 2019 | 265.00 |
| Dec 31, 2018 | 76.00 |
| Sep 30, 2018 | 1,337.00 |
| Jun 30, 2018 | 1,117.00 |
| Mar 31, 2018 | 3,389.00 |
| Dec 31, 2017 | 5,549.00 |
| Sep 30, 2017 | 4,660.00 |
| Jun 30, 2017 | 4.57 Mn |
| Mar 31, 2017 | 91,545.00 |
| Dec 31, 2016 | 171,211.00 |
| Sep 30, 2016 | 590,345.00 |
| Jun 30, 2016 | 693,700.00 |
| Mar 31, 2016 | 1.19 Mn |